Video Shorts

1:56
A Potential Breakthrough for Huntington's Disease
4 hours ago
by
Emily Schoenthaler

0:39
Why Developability Matters in Drug Manufacturing
a day ago
by
Emily Schoenthaler

1:10
AAPS 2026 PharmSci 360: A Video Recap
5 days ago
by
Feliza Mirasol(+2 more)

1:23
A Potential Game Changer for At-Home Medical Treatment
5 days ago
by
Emily Schoenthaler(+1 more)

0:51
The Evolution of Cold Chain: From Preservation to Prediction
5 days ago
by
Feliza Mirasol(+3 more)

1:23
Breaking the 200mg/ml Barrier in Antibody Formulation
6 days ago
by
Emily Schoenthaler(+1 more)

1:38
Why $10 per Gram Matters for Global Access
6 days ago
by
Emily Schoenthaler(+1 more)

0:46
The Truth About Oral Peptide Delivery in 2026
7 days ago
by
Feliza Mirasol(+1 more)

0:37
The Future of AI-Guided Formulations at Pfizer
8 days ago
by
Stephanie Johnson(+2 more)

0:50
Cutting the Cost of Monoclonal Antibody Manufacturing
9 days ago
by
Emily Schoenthaler(+1 more)

0:43
The Challenge of Delivering Oral Peptides
9 days ago
by
Feliza Mirasol(+1 more)

0:49
Breakthrough Personalized mRNA Cancer Vaccine Results
12 days ago
by
Emily Schoenthaler

0:48
FDA Approves First-of-its-Kind Chronic Hepatitis B Treatment
13 days ago
by
Emily Schoenthaler

0:35
Why AI Transparency is Crucial for Science
14 days ago
by
Feliza Mirasol(+1 more)

0:50
The Future of Cancer Treatment: Why Biomarkers Matter
16 days ago
by
Emily Schoenthaler(+2 more)

1:11
Next in Biologics: FDA Reviews First Keytruda Biosimilar Without Phase 3 Trial
21 days ago
by
Emily Schoenthaler

0:48
How Surrogate Endpoints Accelerate Patient Access to Innovation
a month ago
by
Emily Schoenthaler(+2 more)

0:36
Why Amino-Acid Counting Decides Regulatory Fate
a month ago
by
Feliza Mirasol(+1 more)

0:54
Why Basel is the Global Hub for Immune Engineering
a month ago
by
Feliza Mirasol(+1 more)

0:39
Building the Future of Immune Engineering
a month ago
by
Feliza Mirasol(+1 more)

1:15
How AI and 'Lane Assist' are Transforming Cancer Care
a month ago
by
Emily Schoenthaler(+2 more)

0:35
The Core Mission: Translation in Immune Engineering
2 months ago
by
Feliza Mirasol(+1 more)

0:33
Why Structure is the Ultimate Risk Management in M&A
2 months ago
by
Emily Schoenthaler(+1 more)

1:08
How AI Shrinks Clinical Trial Design from Months to Minutes
2 months ago
by
Emily Schoenthaler(+2 more)

0:42
Can Vaccines Overcome Cancer Immune Suppression?
2 months ago
by
Feliza Mirasol(+2 more)

0:35
The Manufacturing Challenge: Scaling Personalized Cancer Treatment
2 months ago
by
Feliza Mirasol(+2 more)

0:40
The Billion-Dollar Secret to a Successful Product Launch
2 months ago
by
Kirsten Detrick(+1 more)

0:43
How AI is Revolutionizing Clinical Trial Patient Matching
3 months ago
by
Eron Kelly(+2 more)

1:02
The Future of AI and Predictive Manufacturing in Pharma
3 months ago
by
Emily Schoenthaler(+1 more)

0:42
How Cancer Vaccines Create a Lifelong Immune 'Police Force'
3 months ago
by
Feliza Mirasol(+2 more)
Advertisement
Advertisement
Trending on BioPharm International
1
Shilpa CDMO Commits $50 Million to Scale Peptide Capacity in India
2
Policy Leaders Urge Treasury to Narrow Biotech Outbound Investment Rule
3
Lonza to Acquire Merck KGaA’s US CDMO Business, Adding ADC, Viral Vector, and LNP Capacity
4
Spyre’s Anti-TL1A Antibody SPY072 Misses in Psoriatic Arthritis and Axial Spondyloarthritis, Shifts Focus to Hidradenitis Suppurativa
5
